New design for monovalent bispecific IgG through cysteine engineering of the CH1-CL interface
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| B [auth L] | PTR2 | e4ub0L1 | A: a/b three-layered sandwiches | X: cradle loop barrel | H: RIFT-related | T: acid protease | F: PTR2 | ECOD (v294.1) |
| A [auth H] | PTR2 | e4ub0H2 | A: a/b three-layered sandwiches | X: cradle loop barrel | H: RIFT-related | T: acid protease | F: PTR2 | ECOD (v294.1) |
| A [auth H] | EF-hand_1, EF-hand_6, EF-hand_7 | e4ub0H3 | A: a/b three-layered sandwiches | X: Lipocalins/Streptavidin | H: SAM/DNA-glycosylase | T: SAM domain-like | F: EF-hand_1, EF-hand_6, EF-hand_7 | ECOD (v294.1) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| B [auth L] | IgG1 Fab | L-KAPPA | Homo sapiens (human) | IGKV1-39*01, IGKV1D-39*01, IGKJ1*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202611-0) |
| A [auth H] | IgG1 Fab | VH-CH1 | Homo sapiens (human) | IGHV3-66*01, IGHV3-66*02, IGHV3-66*04, IGHJ6*01, IGHJ6*02, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202611-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| B [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-03-27) |
| A [auth H] | Heavy Chain | IGHV3 | - | - | SAbDab (2026-03-27) |
| Chain | Name | Target | Provenance Source |
|---|
| B [auth L] | Coprelotamab | ERBB2/CD340/HER2, CD3E, SIRPA, TNFRSF9/CD137/4-1BB | Therapeutic SAbDab (2026-03-27) |
| A [auth H] | Coprelotamab | ERBB2/CD340/HER2, SIRPA, CD3E, TNFRSF9/CD137/4-1BB | Therapeutic SAbDab (2026-03-27) |